Cardiac enzyme elevations after percutaneous coronary intervention: Myonecrosis, the coronary microcirculation and mortality

被引：11

作者：

Harrington, RA ^{[1
]}

机构：

[1] Duke Univ, Med Ctr, Duke Clin Res Inst, Dept Med,Div Cardiol, Durham, NC 27705 USA

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2000年 / 35卷 / 05期

关键词：

D O I：

10.1016/S0735-1097(00)00524-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1142 / 1144

页数：3

共 17 条

[1] Defining the appropriate threshold of creatine kinase elevation after percutaneous coronary interventions [J].

Abdelmeguid, AE ;

Ellis, SG ;

Sapp, SK ;

Whitlow, PL ;

Topol, EJ .

AMERICAN HEART JOURNAL, 1996, 131 (06) :1097-1105

[2] Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions [J].

Abdelmeguid, AE ;

Topol, EJ ;

Whitlow, PL ;

Sapp, SK ;

Ellis, SG .

CIRCULATION, 1996, 94 (07) :1528-1536

[3] The myth of the myocardial 'infarctlet' during percutaneous coronary revascularization procedures [J].

Abdelmeguid, AE ;

Topol, EJ .

CIRCULATION, 1996, 94 (12) :3369-3375

[4] Abciximab facilitates the rate and extent of thrombolysis - Results of the thrombolysis in myocardial infarction (TIMI) 14 trial [J].

Antman, EM ;

Giugliano, RP ;

Gibson, CM ;

McCabe, CH ;

Coussement, P ;

Kleiman, NS ;

Vahanian, A ;

Adgey, AAJ ;

Menown, I ;

Rupprecht, HJ ;

Van der Wieken, R ;

Ducas, J ;

Scherer, J ;

Anderson, K ;

Van de Werf, F ;

Braunwald, E .

CIRCULATION, 1999, 99 (21) :2720-2732

[5] Myonecrosis after revascularization procedures [J].

Califf, RM ;

Abdelmeguid, AE ;

Kuntz, RE ;

Popma, JJ ;

Davidson, CJ ;

Cohen, EA ;

Kleiman, NS ;

Mahaffey, KW ;

Topol, EJ ;

Pepine, CJ ;

Lipicky, RJ ;

Granger, CB ;

Harrington, RA ;

Tardiff, BE ;

Crenshaw, BS ;

Bauman, RP ;

Zuckerman, BD ;

Chaitman, BR ;

Bittl, JA ;

Ohman, EM .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) :241-251

[6] CHARACTERISTICS AND CONSEQUENCES OF MYOCARDIAL-INFARCTION AFTER PERCUTANEOUS CORONARY INTERVENTION - INSIGHTS FROM THE CORONARY ANGIOPLASTY VERSUS EXCISIONAL ATHERECTOMY TRIAL (CAVEAT) [J].

HARRINGTON, RA ;

LINCOFF, AM ;

CALIFF, RM ;

HOLMES, DR ;

BERDAN, LG ;

OHANESIAN, MA ;

KEELER, GP ;

GARRATT, KN ;

OHMAN, EM ;

MARK, DB ;

JACOBS, AK ;

TOPOL, EJ .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 25 (07) :1693-1699

[7]

Kong D. F., 1998, European Heart Journal, V19, P571

[8] Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease [J].

Kong, DF ;

Califf, RM ;

Miller, DP ;

Moliterno, DJ ;

White, HD ;

Harrington, RA ;

Tcheng, JE ;

Lincoff, AM ;

Hasselblad, V ;

Topol, EJ .

CIRCULATION, 1998, 98 (25) :2829-2835

[9] Prognostic implication of creatine kinase elevation following elective coronary artery interventions [J].

Kong, TQ ;

Davidson, CJ ;

Meyers, SN ;

Tauke, JT ;

Parker, MA ;

Bonow, RO .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (06) :461-466

[10] ELEVATION OF THE CREATINE-KINASE MYOCARDIAL ISOFORM FOLLOWING OTHERWISE SUCCESSFUL DIRECTIONAL CORONARY ATHERECTOMY AND STENTING [J].

KUGELMASS, AD ;

COHEN, DJ ;

MOSCUCCI, M ;

PIANA, RN ;

SENERCHIA, C ;

KUNTZ, RE ;

BAIM, DS .

AMERICAN JOURNAL OF CARDIOLOGY, 1994, 74 (08) :748-754

← 1 2 →